Goldman Sachs’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.26B | Sell |
|
|||||
2025
Q1 | $2.96B | Buy |
|
|||||
2024
Q4 | $2.01B | Buy |
|
|||||
2024
Q3 | $2.11B | Sell |
|
|||||
2024
Q2 | $1.99B | Buy |
|
|||||
2024
Q1 | $1.62B | Sell |
|
|||||
2023
Q4 | $1.65B | Sell |
|
|||||
2023
Q3 | $1.6B | Buy |
|
|||||
2023
Q2 | $1.26B | Sell |
|
|||||
2023
Q1 | $1.61B | Buy |
|
|||||
2022
Q4 | $1.43B | Sell |
|
|||||
2022
Q3 | $1.26B | Buy |
|
|||||
2022
Q2 | $1.32B | Sell |
|
|||||
2022
Q1 | $1.5B | Sell |
|
|||||
2021
Q4 | $1.31B | Sell |
|
|||||
2021
Q3 | $1.07B | Buy |
|
|||||
2021
Q2 | $772M | Buy |
|
|||||
2021
Q1 | $711M | Sell |
|
|||||
2020
Q4 | $884M | Sell |
|
|||||
2020
Q3 | $885M | Sell |
|
|||||
2020
Q2 | $1.15B | Sell |
|
|||||
2020
Q1 | $1.07B | Buy |
|
|||||
2019
Q4 | $1.1B | Sell |
|
|||||
2019
Q3 | $965M | Buy |
|
|||||
2019
Q2 | $773M | Sell |
|
|||||
2019
Q1 | $882M | Sell |
|
|||||
2018
Q4 | $1.16B | Sell |
|
|||||
2018
Q3 | $1.26B | Buy |
|
|||||
2018
Q2 | $1.17B | Sell |
|
|||||
2018
Q1 | $1.25B | Buy |
|
|||||
2017
Q4 | $1.27B | Buy |
|
|||||
2017
Q3 | $873M | Buy |
|
|||||
2017
Q2 | $702M | Buy |
|
|||||
2017
Q1 | $536M | Buy |
|
|||||
2016
Q4 | $482M | Buy |
|
|||||
2016
Q3 | $431M | Buy |
|
|||||
2016
Q2 | $386M | Buy |
|
|||||
2016
Q1 | $342M | Sell |
|
|||||
2015
Q4 | $412M | Buy |
|
|||||
2015
Q3 | $321M | Sell |
|
|||||
2015
Q2 | $451M | Sell |
|
|||||
2015
Q1 | $504M | Sell |
|
|||||
2014
Q4 | $583M | Sell |
|
|||||
2014
Q3 | $585M | Buy |
|
|||||
2014
Q2 | $438M | Buy |
|
|||||
2014
Q1 | $376M | Sell |
|
|||||
2013
Q4 | $444M | Buy |
|
|||||
2013
Q3 | $309M | Sell |
|
|||||
2013
Q2 | $289M | Buy |
|